Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(30%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
30%
Ph not_applicable
1
10%
Ph phase_4
1
10%
Ph phase_2
3
30%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(5)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting3
Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 23 (33.3%)
Phase 33 (33.3%)
Phase 41 (11.1%)
N/A1 (11.1%)

Trials by Status

completed440%
not_yet_recruiting220%
recruiting330%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10